Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Stryker Now Expects 2024 Organic Net Sales Growth Of 8.5%-9.5% (Prior 7.5%-9.0%) With Pricing Impact To Be Roughly Flat; Raises Adj EPS Outlook From $11.70-$12.00 To $11.85-$12.05, Est $11.85

Author: Benzinga Newsdesk | April 30, 2024 04:24pm

If foreign exchange rates hold near current levels, the company anticipate net sales will be moderately unfavorably impacted for the full year, being more negative in the first half of the year, and adjusted EPS will be negatively impacted at the higher end of previously guided range of $0.05 to $0.10 for the full year.

Posted In: SYK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist